Evidence tips the scale toward screening for hyperglycemia

Diabetes Care

Volumn 38, Issue 8, 2015, Pages 1399-1401

  Narayan, K M Venkat ^a,b   Gujral, Unjali P ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN;

CARDIOVASCULAR DISEASE; COST EFFECTIVENESS ANALYSIS; EVIDENCE BASED MEDICINE; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH CARE QUALITY; HIGH RISK POPULATION; HUMAN; HYPERGLYCEMIA; INCIDENCE; LIFESTYLE MODIFICATION; MEDICAL LITERATURE; MEDICAL RESEARCH; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PATIENT CARE; PREVALENCE; RISK REDUCTION; SCREENING; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE;

DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS;

EID: 84962427847     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc15-0856     Document Type: Note

References (24)

1. Echouffo-Tcheugui JB, Ali MK, Griffin SJ, Narayan KM. Screening for type 2 diabetes and dysglycemia. Epidemiol Rev 2011;33:63-87.
2. American Diabetes Association. Standards of medical care in diabetesd2010. Diabetes Care 2010;33(Suppl. 1):S11-S61.
3. U.S. Preventive Services Task Force. Screening for type 2 diabetes mellitus in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008;148: 846-854.
4. Herman WH, Ye W, Griffin SJ, et al. Early detection and treatment of type 2 diabetes reduce cardiovascularmorbidityandmortality:asimulation of the results of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen- Detected Diabetes in Primary Care (ADDITIONEurope). Diabetes Care 2015;38:1449-1455.
5. International Diabetes Federation. IDF Diabetes Atlas update poster. In: IDF Diabetes Atlas. 6th ed. Brussels, Belgium, International Diabetes Federation, 2014.
6. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011. Atlanta, GA, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011.
7. Griffin SJ, Borch-Johnsen K, Davies MJ, et al. Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): A cluster-randomised trial. Lancet 2011;378:156-167.
8. Selph SL, Dana T, Blazina I, Bougastos C, Patel H, Chour R. Screening for type 2 diabetes: systematic review to update the U.S. Preventive Services Task Force. Ann InternMed. 14 April 2015 [Epub ahead of print]. DOI:10.7326/M14-2221.
9. Gong Q, Gregg EW, Wang J, et al. Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: The China Da Qing Diabetes Prevention Outcome Study. Diabetologia 2011;54:300-307.
10. Armato J, DeFronzo RA, Abdul-Ghani M, Ruby R. Successful treatment of prediabetes in clinical practice: Targeting insulin resistance and b-cell dysfunction. Endocr Pract 2012;18:342-350.
11. Lindahl B, Nilssön TK, Borch-Johnsen K, et al. A randomized lifestyle intervention with 5-year follow-up in subjects with impaired glucose tolerance: pronounced short-term impact but long-term adherence problems. Scand J Public Health 2009;37:434-442.
12. Orchard TJ, Temprosa M, Goldberg R, et al; Diabetes Prevention Program Research Group. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: The Diabetes Prevention Program randomized trial. Ann Intern Med 2005;142:611-619.
13. Brown JS, Wing R, Barrett-Connor E, et al; Diabetes Prevention Program Research Group. Lifestyle intervention is associated with lower prevalence of urinary incontinence: The Diabetes Prevention Program. Diabetes Care 2006;29: 385-390.
14. Florez H, Pan Q, Ackermann RT, et al; Diabetes Prevention Program Research Group. Impact of lifestyle intervention and metformin on health-related quality of life: The Diabetes Prevention Program randomized trial. J Gen Intern Med 2012;27:1594-1601.
15. Narayan KM, Weber MB. Screening for hyperglycemia: The gateway to diabetes prevention and management for all Americans. Ann Intern Med. 14 April 2015 [Epub ahead of print]. DOI:10.7326/M15-0798.
16. Waugh NR, Shyangdan D, Taylor-Phillips S, Suri G, Hall B. Screening for type 2 diabetes: A short report for the National Screening Committee. Health Technol Assess 2013;17:1-90.
17. DukpaW, TeerawattananonY, Rattanavipapong W, et al. Is diabetes and hypertension screening worthwhile in resource-limited settings? An economic evaluation based on a pilot of a Package of Essential Non-communicable disease interventions in Bhutan. Health Policy Plan. 8 October 2014 [Epub ahead of print].
18. Chatterjee R, Narayan KM, Lipscomb J, Phillips LS. Screening adults for pre-diabetes and diabetes may be cost-saving. Diabetes Care 2010;33:1484-1490.
19. Kahn R, Alperin P, Eddy D, et al. Age at initiation and frequency of screening to detect type 2 diabetes: A cost-effectiveness analysis. Lancet 2010;375:1365-1374.
20. Eborall HC, Griffin SJ, Prevost AT, Kinmonth AL, French DP, Sutton S. Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial. BMJ 2007; 335:486.
21. Ali MK, Bullard KM, Gregg EW, Del Rio C. A cascade of care for diabetes in the United States: visualizing the gaps. Ann Intern Med 2014;161:681-689.
22. Bertram MY, Vos T. Quantifying the duration of pre-diabetes. Aust N Z J Public Health 2010;34:311-314.
23. Gerstein HC, Santaguida P, Raina P, et al. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: A systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract 2007;78:305-312.
24. Lindström J, Peltonen M, Eriksson JG, et al; Finnish Diabetes Prevention Study (DPS). Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS). Diabetologia 2013;56: 284-293.